Nanoparticle Tracking Analysis of Gold Nanoparticles in Aqueous Media through an Inter-Laboratory Comparison
October 20th, 2020
8.2K views
The protocol described here aims to measure the hydrodynamic diameter of spherical nanoparticles, more specifically gold nanoparticles, in aqueous media by means of Nanoparticle Tracking Analysis (NTA). The latter involves tracking the movement of particles due to Brownian motion and implementing the Stokes-Einstein equation to obtain the hydrodynamic diameter.
Overview
This protocol outlines a method for measuring the hydrodynamic diameter of gold nanoparticles in aqueous media using Nanoparticle Tracking Analysis (NTA). The technique leverages Brownian motion and the Stokes-Einstein equation for accurate size determination.
Key Study Components
Area of Science
- Nanoparticle characterization
- Analytical chemistry
- Materials science
Background
- NTA provides real-time analysis of nanoparticles.
- Hydrodynamic diameter is crucial for understanding particle behavior in solutions.
- Gold nanoparticles are widely used in various applications.
- Accurate size measurement is essential for quality control.
Purpose of Study
- To establish a reliable protocol for measuring nanoparticle sizes.
- To enhance reproducibility in nanoparticle analysis across laboratories.
- To validate NTA results with complementary techniques.
Methods Used
- Preparation of ultra-pure water and sample dilution.
- Setup and calibration of the NTA instrument.
- Real-time tracking of nanoparticles to determine size.
- Data analysis and export of results for further validation.
Main Results
- Achieved accurate measurements of gold nanoparticle sizes.
- Demonstrated good repeatability across multiple laboratories.
- Validated NTA results with transmission electron microscopy.
- Average mode size across labs was 62.02 ± 1.97 nanometers.
Conclusions
- The protocol is effective for characterizing nanoparticles.
- Following standard operating procedures enhances accuracy.
- This method can be adapted for other nanomaterials.
Frequently Asked Questions
What is Nanoparticle Tracking Analysis (NTA)?
NTA is a technique used to visualize and measure the size of nanoparticles in real-time based on their Brownian motion.
Why is the hydrodynamic diameter important?
The hydrodynamic diameter helps predict how nanoparticles behave in different environments, which is crucial for applications in drug delivery and diagnostics.
How do you prepare the sample for NTA?
The sample should be diluted in ultra-pure water filtered through a 0.02 micron syringe filter to ensure accuracy in measurements.
What are the advantages of using NTA?
NTA provides quick, reliable, and reproducible measurements with minimal sample preparation, allowing for real-time analysis.
Can this method be used for other nanoparticles?
Yes, this method can be adapted for various nanoparticles, including exosomes and viruses, for characterization and quality control.
Executive Industry Relevance
Robust nanoparticle characterization is critical for biopharma R&D, where particle size directly impacts formulation stability, delivery efficiency, and safety profiles. This inter-laboratory comparison of Nanoparticle Tracking Analysis (NTA) for gold nanoparticles demonstrates the necessity of standardized protocols and reproducible analytics to ensure data integrity across sites. Reliable hydrodynamic diameter measurement underpins predictive confidence in nanoparticle-enabled therapeutics and diagnostics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise assessment of nanoparticle size distributions for mechanistic de-risking in delivery system development.
- Supports functional validation of nanomaterial properties relevant to biological targeting and uptake.
- Facilitates portfolio triage by providing reproducible, quantitative particle metrics for candidate selection.
Screening & Assay Development
- Prepares validated nanoparticle suspensions for downstream biological assays and screening workflows.
- Ensures assay standardization and reproducibility through harmonized SOPs and instrument settings.
- Delivers quantitative outputs that enable reliable comparison of nanoparticle formulations and batches.
- Supports scalability and platform reuse by establishing cross-lab measurement consistency.
Translational & Preclinical Research
- Aligns nanoparticle characterization with translational biomarker requirements for preclinical studies.
- Maintains continuity from discovery through preclinical validation by enabling cross-functional data comparability.
- Reduces risk in advancing nanomaterial-based candidates by providing validated, reproducible size data.
Pipeline & Workflow Integration
NTA-based hydrodynamic diameter measurement integrates from early discovery through preclinical development, supporting lead identification and formulation optimization.
- Discovery Biology: Provides quantitative size data to test hypotheses about nanoparticle behavior and biological interactions.
- Screening: Delivers reproducible, standardized measurements essential for assay readiness and batch-to-batch comparison.
- Analytics: Generates exportable, quantitative outputs for statistical analysis and cross-lab benchmarking.
- Translational Research: Supports alignment with preclinical biomarker and stability requirements when advancing candidates.
- Enterprise Reuse: Establishes a validated, transferable protocol for nanoparticle characterization across programs and sites.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in nanoparticle-enabled R&D.
- Operational Value: Drives standardization, reproducibility, and scalability of nanoparticle analytics.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient advancement of nanomaterial candidates.
- Portfolio Impact: Supports risk-adjusted prioritization and cross-program comparability of nanoparticle data.
Implementation Considerations
- Requires technical expertise in NTA instrumentation and data interpretation.
- Depends on access to calibrated NTA systems and complementary analytical infrastructure.
- Necessitates rigorous cross-team adherence to standardized SOPs for reproducibility.
- May require adaptation of protocols for different nanoparticle types or biological matrices.
- Potential limitations include sensitivity to sample preparation and instrument configuration, as highlighted by inter-lab variability.
Biopharma FAQs
Why does null hypothesis testing matter for NTA-based target validation?
Null hypothesis testing in NTA data analysis enables objective assessment of whether observed nanoparticle size distributions differ significantly between formulations or batches. This statistical rigor is essential for validating that changes in particle size are attributable to experimental variables rather than measurement noise, supporting confident target validation decisions.
How does independent variable isolation fit the inter-lab NTA workflow?
Isolating independent variables, such as instrument settings and SOP adherence, is critical in inter-laboratory NTA studies to ensure that observed differences in particle size measurements reflect true sample variation. This approach underpins reproducibility and comparability across sites, strengthening the reliability of nanoparticle analytics in the discovery pipeline.
What do quantitative dependent variable measurements enable in NTA analysis?
Quantitative measurement of hydrodynamic diameter as a dependent variable allows teams to benchmark nanoparticle formulations, assess batch consistency, and support statistical analysis for decision-making. These outputs are foundational for cross-functional data integration and portfolio-level evaluation of nanomaterial candidates.
Why are replication requirements important for cross-functional NTA collaboration?
Replication across multiple laboratories and runs ensures that NTA results are robust, reproducible, and not site-dependent. This is vital for cross-functional collaboration, enabling reliable data sharing and joint advancement decisions in multi-site biopharma R&D environments.
What statistical analysis capabilities are required before implementing NTA SOPs?
Effective implementation of NTA SOPs requires statistical tools for assessing repeatability, inter-lab variability, and significance of observed differences. These capabilities ensure that measurement outputs meet quality thresholds and support risk-adjusted advancement of nanoparticle-enabled programs.
